These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1095 related articles for article (PubMed ID: 2683995)
1. Transforming growth factor release by human tumor cell lines and their interactions with other growth factors. Rueda F; Piñol G; Gonzalez-Garrigues M; Marti F; Fabra A Anticancer Res; 1989; 9(4):1245-8. PubMed ID: 2683995 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide. Eppstein DA; Marsh YV; Schryver BB; Bertics PJ J Cell Physiol; 1989 Nov; 141(2):420-30. PubMed ID: 2530243 [TBL] [Abstract][Full Text] [Related]
3. Production of transforming growth factors by human colon cancer lines. Coffey RJ; Shipley GD; Moses HL Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610 [TBL] [Abstract][Full Text] [Related]
4. [The effect of epidermal growth factor and insulin on the specific binding of transforming growth factor beta by NRK-49F and A-459 cell lines]. Sushel'nitskiĭ SI; Stoĭka RS; Kusen' SI Tsitologiia; 1991; 33(3):80-7. PubMed ID: 1666203 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha. Rodeck U; Williams N; Murthy U; Herlyn M J Cell Biochem; 1990 Oct; 44(2):69-79. PubMed ID: 2250044 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281 [TBL] [Abstract][Full Text] [Related]
7. The growth promoting effect of transforming growth factor-alpha in human breast cancer cell lines. Kuranami M; Yamaguchi K; Asanuma F; Suzuki M; Abe K Jpn J Clin Oncol; 1989 Dec; 19(4):360-6. PubMed ID: 2607638 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines. Reynolds RK; Hu C; Baker VV Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691 [TBL] [Abstract][Full Text] [Related]
9. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells. Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020 [TBL] [Abstract][Full Text] [Related]
10. [Growth factors produced by rat glioma cells: activities of transforming growth factors]. Kanno H; Shinonaga M; Kuwabara T; Umeda M No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559 [TBL] [Abstract][Full Text] [Related]
11. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Fan Z; Masui H; Altas I; Mendelsohn J Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927 [TBL] [Abstract][Full Text] [Related]
12. Growth factor production by human colon carcinoma cell lines. Anzano MA; Rieman D; Prichett W; Bowen-Pope DF; Greig R Cancer Res; 1989 Jun; 49(11):2898-904. PubMed ID: 2541895 [TBL] [Abstract][Full Text] [Related]
14. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha. Ethier SP; Langton BC; Dilts CA Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580 [TBL] [Abstract][Full Text] [Related]
15. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. Korc M; Haussler CA; Trookman NS Cancer Res; 1987 Sep; 47(18):4909-14. PubMed ID: 3497713 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture. Liu C; Tsao MS; Grisham JW Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400 [TBL] [Abstract][Full Text] [Related]
18. [The effect of the beta-type transforming growth factor and its combination with epidermal growth factor and insulin on substrate-dependent proliferation of normal and tumor cells]. Sushel'nitskiĭ SI; Stoĭka RS; Garas'ko SI; Shafranskaia GI; Kusen' SI Tsitologiia; 1989 Jul; 31(7):767-74. PubMed ID: 2683271 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-alpha secretion by epidermal growth factor-dependent human tumor cell lines. Singletary SE; Williams NN; Rodeck U; Larry L; Tucker S; Spitzer G; Herlyn M Anticancer Res; 1990; 10(6):1501-5. PubMed ID: 2285223 [TBL] [Abstract][Full Text] [Related]
20. Growth factor production by a human megakaryocytic tumor cell line. Witte DP; Stambrook PJ; Feliciano E; Jones CL; Lieberman MA J Cell Physiol; 1988 Oct; 137(1):86-94. PubMed ID: 3049629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]